2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6027 | Delanzomib | CEP-18770 | Apoptosis , NF-κB , Proteasome |
Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome. | |||
T69288 | CEP-7055 | ||
CEP-18770 is an orally bioavailable synthetic P2 threonine boronic acid inhibitor of the chymotrypsin-like activity of the proteasome, with potential antineoplastic activity. Proteasome inhibitor CEP 18770 represses the ... |